Apecotrep (BI 764198) is a potential first-in-class, oral, selective TRPC6 inhibitor being investigated as a novel, targeted, non-immunosuppressive therapy in people with primary focal segmental ...
The endothelial glycocalyx integrates mechanical signals with vascular biology, playing a vital role in health and disease, ...
Zacks Investment Research on MSN
NVO expands Aspect tie-up to advance curative diabetes cell therapies
Novo Nordisk NVO and Aspect Biosystems announced that they are advancing their partnership into a new phase focused on developing next-generation cellular medicines for diabetes. The companies have ...
Soley Therapeutics has secured $200 million in series C funds, which the artificial-intelligence-enabled biotech plans to use to take its lead acute myeloid leukemia (AML) asset into the clinic. The ...
It's been a long time coming: Four years after Omeros came up short in its bid to gain an FDA approval for stem cell transplant drug narsoplimab, the Seattle biotech has finally scored its ...
MIDLAND, Texas--(BUSINESS WIRE)--Permian Resources Corporation (NYSE: PR) (“Permian Resources,” “we,” “us,” “our” or the “Company”) today ...
Dec 15 (Reuters) - Kyverna Therapeutics (KYTX.O), opens new tab said its experimental cell therapy met the main goal of "significantly" improving patients' ability to walk and reducing muscle ...
Duke and head coach Jon Scheyer have already done a fantastic job in the 2026 recruiting cycle. So far, the Blue Devils have landed commitments from three elite prospects: Bryson Howard, a five-star ...
Five hundred fifty-three students from 10 countries, 45 states, the District of Columbia, and Puerto Rico were admitted to Johns Hopkins University today. These first members of the undergraduate ...
Natural killer (NK) cells are the bodyguards of our immune system. As a first line of defense, they destroy invading pathogens, foreign bodies, and infected cells in early stages, thereby preventing ...
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results